Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia.
Yumi AokiYoshikazu TakaesuKentaro MatsuiTakahiro TokumasuHideaki TaniYoshiteru TakekitaTetsufumi KanazawaTaishiro KishimotoSeiichiro TarutaniNaoki HashimotoHiroyoshi TakeuchiKazuo MishimaKen InadaPublished in: Neuropsychopharmacology reports (2023)
A DA was successfully developed for schizophrenia, considering whether to reduce antipsychotics, which can be used in the SDM process.
Keyphrases